<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03594097</url>
  </required_header>
  <id_info>
    <org_study_id>HS21905 (B2018:052)</org_study_id>
    <nct_id>NCT03594097</nct_id>
  </id_info>
  <brief_title>Use of Coconut Nourish and Queen Garnet Plum to Improve Health in an Elderly Population</brief_title>
  <official_title>Use of Coconut Nourish and Queen Garnet Plum to Improve Health in an Elderly Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern Queensland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Advance Queensland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nutrafruit Pty Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nature Pacific Pty Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify whether the combination of coconut Nourish and Queen
      Garnet plum are able to attenuate ageing-related complications, including muscle mass loss
      and inflammation. The study endpoints will measure muscle mass as the primary endpoint with
      blood lipids, glucose, blood pressure, and inflammatory markers serving as some of the
      secondary endpoints. As the two products are rich in dietary fibre and anthocyanins,
      respectively, the study outcome will help to understand role of these dietary components in
      improving complications that are seen quite frequently in elderly population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 4, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lean mass</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using dual-energy x-ray absorptiometry (DXA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>8 weeks</time_frame>
    <description>Weight and height will be combined to report BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arm circumference</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wrist circumference</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calf circumference</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triceps skinfold</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Five times chair standing test</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip dynamometer</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>8 weeks</time_frame>
    <description>Systolic and diastolic pressure will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral content</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured using DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood total cholesterol</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood low-density lipoprotein cholesterol</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood high-density lipoprotein cholesterol</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood triglycerides</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood C-reactive protein</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood interleukin 1 beta</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood tumor necrosis factor alpha</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy Ageing</condition>
  <arm_group>
    <arm_group_label>Treatment cookies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control cookies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment cookies</intervention_name>
    <description>Plain flour, Coconut Nourish, Queen Garnet Plum, Unsalted Butter, Artificial Sweetener</description>
    <arm_group_label>Treatment cookies</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control cookies</intervention_name>
    <description>Plain flour, Coconut Powder, Unsalted Butter, Artificial Sweetener, Food Colour</description>
    <arm_group_label>Control cookies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 65 years and above

          -  Able to give written informed consent

          -  Able to read, write and speak English

          -  Body mass index less than or equal to 30 kg/m^2

          -  Either do not suffer from a chronic disease or, if suffering from a chronic disease,
             then key parameters (blood pressure, blood lipids concentration and blood glucose
             concentrations) are within the normal physiological range

          -  Either take no chronic medication or have been treated with a stable dosage of
             medication for at least 3 months as confirmed by family physician.

          -  Either take no supplements, or have been utilizing supplements in a stable and
             consistent dose for at least 3 months, and plan to continue taking a stable and
             consistent dose throughout the entire study.

        Exclusion Criteria:

          -  Smokers

          -  Consumption of more than 2 alcoholic drinks/day, or &gt; 14 alcoholic beverages a week,
             or history of alcoholism or drug dependence

          -  Uncontrolled hypertension, recent stroke or myocardial infarction, hypothyroidism,
             diabetes mellitus or kidney disease

          -  Major disability or disorder requiring continuous medical attention and treatment such
             as chronic heart failure, liver disease, renal failure or cancer, chronic infections
             or major surgery within 6 months prior to randomization

          -  Despite taking medication, do not have values for key parameters (blood pressure,
             blood lipids concentration and blood glucose concentrations) within normal
             physiological ranges

          -  Fasting glucose ≥ 5.6 mmol/L

          -  Triglycerides ≥ 1.7 mmol/L

          -  Systolic and diastolic blood pressures ≥130/85 mmHg

          -  High-density lipoprotein cholesterol ≤1.0 mmol/L

          -  Have gained or lost &gt;10 lbs in the previous 3 months, or plan to lose weight at any
             time during the study

          -  History of allergy to coconut, plum, plain flour, butter or milk

          -  Any planned surgeries during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Jones, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie Jew, BSc</last_name>
    <phone>204-272-1549</phone>
    <email>stephanie.jew@umanitoba.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Southern Queensland</name>
      <address>
        <city>Toowoomba</city>
        <state>Queensland</state>
        <zip>4350</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sunil Panchal, PhD</last_name>
      <phone>+61-7-4631-1012</phone>
      <email>sunil.panchal@usq.edu.au</email>
    </contact>
    <investigator>
      <last_name>Sunil Panchal, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 6C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Jew</last_name>
      <phone>204-272-1549</phone>
      <email>stephanie.jew@umanitoba.ca</email>
    </contact>
    <investigator>
      <last_name>Peter JH Jones, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>July 10, 2018</study_first_submitted>
  <study_first_submitted_qc>July 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

